Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
Mazen Noureddin, Shaharyar Khan, Francisco Portell, Diane Jorkasky, Jameel Dennis, Omer Khan, Lars Johansson, Edvin Johansson, Arun J. Sanyal
- Academic Institute
- Charles W. Duncan Jr. Department of Medicine
- Sherrie and Alan Conover Center for Liver Disease & Transplantation
- Underwood Center for Digestive Health
- J.C. Walter Jr. Transplant Center
- Houston Methodist Hospital
- Houston Methodist
- Weill Cornell Medical College
- Dr. Mary and Ron Neal Cancer Center
Research output: Contribution to journal › Article › peer-review
38
Link opens in a new tab
Scopus
citations